PHA (polyhydroxyalkanoates) is drawing attention across medical supply chains as a bioplastic made from renewable feedstocks that degrades without persistent microplastic residue. One question comes first for any procurement team: what does “medical grade” mean for this material, and which standards apply?
What Does Medical Grade Mean for a Bioplastic
“Medical grade” is not a single certification. It is a threshold that separates commodity polymers, food-contact polymers, and polymers acceptable for use in or around the human body. Commodity grades are optimized for cost and processability. Food-contact grades must satisfy migration and safety limits. Medical grades must demonstrate biocompatibility, controlled impurities, and reproducible manufacturing under GMP.
For PHA (polyhydroxyalkanoates), the gap between grades is wider than for mature polymers. PHA is produced by bacterial fermentation, so the resin can carry residual biomass, proteins, endotoxins, and catalyst or solvent traces depending on the purification train. Endotoxin control matters most for materials that contact blood or tissue. A documented purification process is the difference between a resin that can be evaluated under ISO 10993 and one that cannot.
ISO 10993: The Biological Evaluation Framework
ISO 10993 is the international framework for the biological evaluation of medical devices. ISO 10993-1 takes a risk-based approach: the manufacturer plans the evaluation from the device’s materials, intended use, and duration of patient contact. It is the master standard that determines which tests apply, including:
- ISO 10993-5: tests for in vitro cytotoxicity
- ISO 10993-10: tests for sensitization and irritation
- ISO 10993-11: tests for systemic toxicity
- ISO 10993-3: tests for genotoxicity
- ISO 10993-6: tests for local effects after implantation
Compliance is documented in a biological evaluation report covering material characterization, test selection rationale, results, and residual risk. Suppliers of medical-grade PHA resins typically share test summaries and certificates of analysis; devices built from those resins carry the full evaluation. Buyers should ask which tests were run, on which lots, and by which laboratory.
Regulatory Pathways for PHA Devices
The polymer itself is not the regulated product; the device is. A PHA-based mesh, suture, or implant follows the same pathways as any other medical device. In the United States, the FDA regulates devices by class: a 510(k) premarket notification for moderate-risk devices that can show substantial equivalence to a predicate, De Novo classification for novel low-to-moderate-risk devices without a predicate, and premarket approval (PMA) for high-risk devices. FDA’s 510(k) database records cleared products.
In Canada, the Medical Devices Regulations classify devices from Class I to Class IV by risk. A Medical Device Licence (MDL) is required for Classes II through IV, and a Medical Device Establishment Licence (MDEL) for importers and distributors. In the European Union, devices must satisfy the Medical Device Regulation (EU) 2017/745, including CE marking. Every pathway requires ISO 10993 biological evaluation data.
What’s Cleared Today
Honest status: PHA-family products have cleared regulatory review, but the field is young. Poly-4-hydroxybutyrate (P4HB), a member of the PHA family, is the most advanced example. Tepha developed P4HB-based absorbable materials; FDA-cleared products such as Phasix mesh for hernia repair have been marketed for years. These are documented clearances, not projections.
Broader adoption remains early. Cleared devices built on PLA-family polymers (polyglactin 910 sutures such as Vicryl, for example) are far more numerous. Commercial medical-grade supply is still consolidating around a small number of producers. Peer-reviewed reviews track this progress closely.
How to Verify Medical Grade Claims
Procurement teams evaluating any bioplastic for medical use should request a standard set of documents:
- ISO 10993 test summaries covering the relevant biological endpoints
- Resin certificate of analysis with impurity and endotoxin data
- Sterilization validation for the intended method (EtO or gamma)
- Change notification commitments from the manufacturer
CliniEco applies the same discipline to its existing PLA supply line. Our biodegradable isolation gowns and 30-gallon biodegradable waste bags are produced from PLA resin, and we maintain traceability from resin lot to finished product while the PHA category matures. Our nitrile gloves complete the disposable line. Until medical-grade PHA supply is as documented as PLA, this checklist is the practical gate.
FAQ
Is all PHA medical grade?
No. Most commercial PHA is commodity or industrial grade. Medical-grade PHA must demonstrate biocompatibility under ISO 10993, controlled endotoxin and impurity levels, and consistent manufacturing under a quality system. Grade claims should always be verified with documentation.
What is P4HB?
P4HB (poly-4-hydroxybutyrate) is a specific member of the PHA family used in absorbable medical devices. Tepha’s P4HB technology underlies FDA-cleared products including Phasix mesh for soft tissue repair. It is the most commercially advanced PHA in medical use today.
Does CliniEco sell PHA products today?
Not yet. CliniEco offers PLA-based biodegradable products, including isolation gowns and 30-gallon waste bags. We will introduce PHA products only when medical-grade supply and documentation meet our standards.
Related Reading
Explore more guides in this category:
0 comments